Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: FDC Limited

Capitalization 6.01TCr 65Cr 56Cr 51Cr 49Cr 89Cr 91Cr 600.92Cr 239.54Cr 2.87TCr 244.51Cr 239.36Cr 10TCr P/E ratio 2024
22.8x
P/E ratio 2025 24.1x
Enterprise value 5.49TCr 60Cr 51Cr 46Cr 44Cr 81Cr 83Cr 549.43Cr 219.01Cr 2.63TCr 223.56Cr 218.85Cr 9.46TCr EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.12%
Yield 2024 *
-
Yield 2025 1.27%
1 day-2.38%
1 week-0.81%
Current month+3.48%
1 month-7.06%
3 months-12.79%
6 months-19.76%
Current year-12.77%
1 week 351.55
Extreme 351.55
385
1 month 349.25
Extreme 349.25
395.1
Current year 349.25
Extreme 349.25
421.75
1 year 349.25
Extreme 349.25
527.8
3 years 245.25
Extreme 245.25
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 16/11/2009
Change 5d. change 1-year change 3-years change Capi.($)
-2.38%-0.81% - - 67Cr
-0.15%-0.78%+20.50%+217.39% 89TCr
-0.30%-1.52%+44.90%+60.27% 59TCr
+0.30%-2.64%+5.09%+52.08% 40TCr
-1.55%-7.15%+7.35%+25.17% 35TCr
-0.62%-4.08%+19.59%+62.48% 30TCr
-1.16%-3.00%+22.31%+35.39% 31TCr
-0.75%-3.02%+22.03%+7.91% 29TCr
+0.59%+0.17%+15.36%+65.73% 20TCr
-1.72%-1.24%+24.56%+83.65% 18TCr
Average -0.85%-2.00%+20.19%+67.78% 39.01TCr
Weighted average by Cap. -0.65%-1.91%+21.65%+91.17%

Financials

2024 2025
Net sales 1.94TCr 21Cr 18Cr 16Cr 16Cr 29Cr 29Cr 194.29Cr 77Cr 929.01Cr 79Cr 77Cr 3.35TCr 2.11TCr 23Cr 20Cr 18Cr 17Cr 31Cr 32Cr 210.81Cr 84Cr 1.01TCr 86Cr 84Cr 3.63TCr
Net income 305.22Cr 3.31Cr 2.86Cr 2.58Cr 2.47Cr 4.5Cr 4.63Cr 31Cr 12Cr 145.94Cr 12Cr 12Cr 525.67Cr 266.79Cr 2.89Cr 2.5Cr 2.26Cr 2.16Cr 3.93Cr 4.04Cr 27Cr 11Cr 127.56Cr 11Cr 11Cr 459.48Cr
Net Debt -454.93Cr -4.93Cr -4.26Cr -3.85Cr -3.68Cr -6.71Cr -6.9Cr -45Cr -18Cr -217.52Cr -19Cr -18Cr -783.5Cr -514.96Cr -5.58Cr -4.83Cr -4.36Cr -4.17Cr -7.59Cr -7.81Cr -51Cr -21Cr -246.23Cr -21Cr -21Cr -886.88Cr
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
11/26/11 369.05 -2.38% 1,12,102
10/26/10 378.05 +1.65% 52,686
09/26/09 371.90 +2.69% 1,77,279
06/26/06 362.15 -1.62% 60,404
05/26/05 368.10 -0.90% 41,610
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW